What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Nuclear Medicine

• Publication date

  2017-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2967/jnumed.116.176628PMID 27469358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetic modeling and long‐term test‐retest reproducibility of the mGluR5 PET tracer 18F‐FPEB in human brain

  2016cited by this paper
• Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813

  2015cited by this paper
• Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects

  2013cited by this paper
• PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5).

  2012cited by this paper
• Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo.

  2012cited by this paper
• Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging.

  2012cited by this paper
• Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.

  2012cited by this paper
• Alcohol and the human brain: a systematic review of different neuroimaging methods.

  2011cited by this paper
• Synthesis, characterization, and monkey PET studies of [18F]MK‐1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK‐5435

  2011cited by this paper
• Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease

  2010cited by this paper
• Radiosynthesis and evaluation of [11C]YM-202074 as a PET ligand for imaging the metabotropic glutamate receptor type 1.

  2010cited by this paper
• Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression.

  2010cited by this paper
• Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.

  2010cited by this paper
• Group I metabotropic glutamate receptor signalling and its implication in neurological disease.

  2010cited by this paper
• Synthesis, in vitro and in vivo evaluation of [11C]MMTP: a potential PET ligand for mGluR1 receptors.

  2010cited by this paper
• A population-average MRI-based atlas collection of the rhesus macaque

  2009cited by this paper
• Promise of mGluR2/3 activators in psychiatry

  2009cited by this paper
• The glutamate homeostasis hypothesis of addiction

  2009cited by this paper
• Metabotropic Glutamate Receptor 2 and 3 Gene Expression in The Human Prefrontal Cortex and Mesencephalon in Schizophrenia

  2008cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Human Heart Glutamate Receptors—Implications for Toxicology, Food Safety, and Drug Discovery

  2007cited by this paper
• Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2).

  2005cited by this paper
• Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

  2005cited by this paper
• Ionotropic and metabotropic glutamate receptor structure and pharmacology

  2005cited by this paper
• Evaluation of [3H]LY341495 for labeling group II metabotropic glutamate receptors in vivo.

  2003cited by this paper
• Localization of metabotropic glutamate receptor type 2 in the human brain.

  1999cited by this paper
• Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody.

  1998cited by this paper
• Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat.

  1993cited by this paper

• PET imaging with [¹¹C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington’s disease

  2025cites this paper
• Dusting off old blueprints: Is it time to reconsider metabotropic glutamate receptor 2 for therapeutic drug development?

  2024cites this paper
• Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2

  2024cites this paper
• Distribution of [

  2023cites this paper
• Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

  2023cites this paper
• Synthesis and Characterization of 5-(2-Fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide as a PET Imaging Ligand for Metabotropic Glutamate Receptor 2.

  2022cites this paper
• Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [11C]CHDI-00485180-R and [11C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin

  2022cites this paper
• PET imaging studies to investigate functional expression of mGluR2 using [11C]mG2P001

  2021cites this paper
• Design, synthesis, and characterization of [18F]mG2P026 as a high contrast PET imaging ligand for metabotropic glutamate receptor 2

  2021cites this paper
• Identification and Development of A New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[ 11 C]methoxyphenyl)-5-((1-methyl-1 H -pyrazol-3-yl)methoxy)picolinamide for Imaging Metabotropic Glutamate Receptor Subtype 2 (mGlu 2 )

  2021cites this paper
• Synthesis and characterization of 5-(2-fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide as a PET imaging ligand for metabotropic glutamate receptor 2

  2021cites this paper
• Design, Synthesis and Characterization of Benzimidazole Derivatives as PET Imaging Ligands for Metabotropic Glutamate Receptor Subtype 2 (mGluR2)

  2021cites this paper
• Synthesis and Characterization of [18F]JNJ-46356479 as the First 18F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2

  2021influential citation
• Design, Synthesis and Characterization of Benzimidazole Derivatives as PET Imaging Ligands for Metabotropic Glutamate Receptor 2 (mGluR2).

  2020cites this paper
• Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors

  2020cites this paper
• Molecular Imaging of Depressive Disorders

  2020cites this paper
• Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease

  2020cites this paper
• 3-(Cyclopropylmethyl)-7-((4-(4-[11C]methoxyphenyl)piperidin-1-yl)methyl)-8-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine: Synthesis and Preliminary Evaluation for PET Imaging of Metabotropic Glutamate Receptor Subtype 2.

  2020cites this paper
• Synthesis and preliminary studies of 11C-labeled tetrahydro-1,7-naphthyridine-2-carboxamides for PET imaging of metabotropic glutamate receptor 2

  2020cites this paper
• Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[11C]methoxyphenyl)-5-((1-methyl-1H-pyrazol-3-yl)methoxy)picolinamide for Imaging Metabotropic Glutamate Receptor Subtype 2 (mGlu2).

  2020cites this paper
• A concise method for fully automated radiosyntheses of [18F]JNJ-46356479 and [18F]FITM via Cu-mediated 18F-fluorination of organoboranes

  2020cites this paper
• A case study of foliglurax, the first clinical mGluR4 PAM for symptomatic treatment of Parkinson’s disease: translational gaps or a failing industry innovation model?

  2020cites this paper
• A Review of Molecular Imaging of Glutamate Receptors

  2020cites this paper
• Quality of Research Tools.

  2019cites this paper
• Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience

  2019cites this paper
• Imaging metabotropic glutamate receptor system: Application of positron emission tomography technology in drug development

  2019cites this paper
• Synthesis and evaluation of 4-(2-fluoro-4-[11C]methoxyphenyl)-5-((2-methylpyridin-4-yl)methoxy)picolinamide for PET imaging of the metabotropic glutamate receptor 2 in the rat brain.

  2019cites this paper
• Synthesis and Pharmacological Characterization of C4β-Amide-Substituted 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1 S,2 S,4 S,5 R,6 S)-2-Amino-4-[(3-methoxybenzoyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2794193), a Highly Potent and Selective mGlu3 Receptor Agon

  2018cites this paper
• Gray Matter Volume of a Region in the Thalamic Pulvinar Is Specifically Associated with Novelty Seeking

  2018cites this paper
• Differential Pharmacology and Binding of mGlu2 Receptor Allosteric Modulators

  2018cites this paper
• Approaches for the discovery of novel positron emission tomography radiotracers for brain imaging

  2017cites this paper
• Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2.

  2017cites this paper
• Synthesis and preliminary studies of a novel negative allosteric modulator [11C]QCA for imaging of metabotropic glutamate receptor 2

  2017cites this paper
• Synthesis and in vitro evaluation of three novel radiotracers for imaging of metabotropic glutamate receptor subtype 2 in rat brain.

  2017cites this paper